The American review of respiratory disease · 1980
Effect of chlorphentermine on the pulmonary disposition of 5-hydroxytryptamine in the isolated perfused rabbit lung.
СтатьяПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Angevine L S, Mehendale H M
Аннотация
It has been postulated that chlorphentermine (CP), as well as other drugs known to accumulate and to induce morphologic changes in lung tissue, might affect the uptake and metabolism of the endogenous vasopressor amine, 5-hydroxytryptamine (5-HT). The uptake and metabolism of [14C]5-HT was followed in artificially ventilated, isolated perfused rabbit lung preparations using erythrocyte-free perfusate with an initial 5-HT concentration of 5 microgram/100 ml. Samples of the perfusate were analyzed for total radioactivity, metabolites, and the parent compound. Preloading the lungs with 25 or 30 mumoles of CP significantly decreased the formation of 5-hydroxyindolacetic acid (5-HIAA) to 56% and 34% of the control value, respectively. These experiments indicated that decreased pulmonary metabolism of 5-HT by CP might be mediated via a dual effect of hindered uptake and inhibition of metabolism. In experiments designed to examine the effect on uptake by blocking 5-HT metabolism, CP significantly decreased 5-HT uptake by lungs preloaded with pargyline. In other experiments designed to examine the effect of CP on 5-HT metabolism, CP (0.3 mM) significantly inhibited 5-HT metabolism by 60% in in vitro incubations of rabbit lung homogenates. These experiments provided evidence that CP significantly decreases the pulmonary uptake and metabolism of 5-HT. Decreased pulmonary 5-HT clearance may bear a causal relation to the drug-induced pulmonary hypertension observed with chronic CP treatment.